基本信息
浏览量:3
职业迁徙
个人简介
Research interests
Within Kids Neuroscience Centre, Prof Cooper leads two interconnected research themes via the Genomic Medicine and Disease Mechanism and Therapies groups.
Over the last five years, Prof Cooper’s Genomic Medicine team have been working closely with KNC alumni A/Prof Daniel MacArthur (The Broad Institute of Harvard and MIT) and A/Prof Monkol Lek (Yale School of Medicine) to harness latest innovations in genomics to find genetic answers for Australasian families with inherited nerve, muscle or brain disorders. This research has provided a precise genetic diagnosis for 61 % (132/214) families with genetic neuromuscular conditions, who otherwise would not have an informative genetic explanation for their condition.
In order to achieve a diagnosis for our remaining undiagnosed families, we look to lessons learnt from the diagnosed cohort. We expected families pre-screened for common causes of neuromuscular disorders to be enriched for novel disease genes. However, novel disease genes account for only 5% of diagnosed families; we instead commonly identified ‘tricky’ variants in known disease genes that had been missed. Importantly, one third of our 132 diagnosed families (45/132) are now shown to bear (at least) one causal variant that disrupts mRNA splicing. Therefore, a current major focus of Prof Cooper’s research is the development of informatics and technical pipelines to detect, and confirm the splice-altering behaviour of, causative splicing variants in genetic disorders.
Prof Cooper also leads the Disease Mechanism and Therapies group. This research is closely linked to real-life families with neuromuscular disorders, using their genetic variants as a key to unlock core mechanistic pathways causing disease. The overarching goal of her mechanistic research program is to focus on core stress response pathways shared by common disorders (redox distress, membrane repair with injury, protein misfolding and aggregation) - with the vision to highlight clinical utility of therapies developed for common disorders, for our families with rare disorders.
Within Kids Neuroscience Centre, Prof Cooper leads two interconnected research themes via the Genomic Medicine and Disease Mechanism and Therapies groups.
Over the last five years, Prof Cooper’s Genomic Medicine team have been working closely with KNC alumni A/Prof Daniel MacArthur (The Broad Institute of Harvard and MIT) and A/Prof Monkol Lek (Yale School of Medicine) to harness latest innovations in genomics to find genetic answers for Australasian families with inherited nerve, muscle or brain disorders. This research has provided a precise genetic diagnosis for 61 % (132/214) families with genetic neuromuscular conditions, who otherwise would not have an informative genetic explanation for their condition.
In order to achieve a diagnosis for our remaining undiagnosed families, we look to lessons learnt from the diagnosed cohort. We expected families pre-screened for common causes of neuromuscular disorders to be enriched for novel disease genes. However, novel disease genes account for only 5% of diagnosed families; we instead commonly identified ‘tricky’ variants in known disease genes that had been missed. Importantly, one third of our 132 diagnosed families (45/132) are now shown to bear (at least) one causal variant that disrupts mRNA splicing. Therefore, a current major focus of Prof Cooper’s research is the development of informatics and technical pipelines to detect, and confirm the splice-altering behaviour of, causative splicing variants in genetic disorders.
Prof Cooper also leads the Disease Mechanism and Therapies group. This research is closely linked to real-life families with neuromuscular disorders, using their genetic variants as a key to unlock core mechanistic pathways causing disease. The overarching goal of her mechanistic research program is to focus on core stress response pathways shared by common disorders (redox distress, membrane repair with injury, protein misfolding and aggregation) - with the vision to highlight clinical utility of therapies developed for common disorders, for our families with rare disorders.
研究兴趣
论文共 111 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Pathology (2024): S20-S21
Parvathy Venugopal,Peer Arts,Lucy Claire Fox,Annet Simons,Devendra K Hiwase,Peter G Bardy, Annette Narcis,David M Ross, Lize F D van Vulpen,Arjan Buijs,Kelly L Bolton, Bartlomiej Getta,
Blood advances (2024)
Ana Töpf,Dan Cox,Irina T. Zaharieva, Valeria Di Leo, Jaakko Sarparanta, Per Harald Jonson, Ian M. Sealy, Andrei Smolnikov, Richard J. White,Anna Vihola,Marco Savarese, Munise Merteroglu,
Rhett G Marchant,Samantha J Bryen,Melanie Bahlo,Anita Cairns, Katherine R Chao, Alastair Corbett,Mark R Davis,Vijay S Ganesh,Roula Ghaoui,Kristi J Jones,Andrew J Kornberg,Monkol Lek,
Annals of clinical and translational neurology (2024)
Tania M Larrinaga,Gerrie P Farman,Rachel M Mayfield, Michaela Yuen,Rebecca C Ahrens-Nicklas,Sandra T Cooper, Christopher T Pappas,Carol C Gregorio
Science advancesno. 11 (2024): eadk1890-eadk1890
Patrick Yap,Lisa G. Riley,Purvi M. Kakadia,Stefan K. Bohlander, Ben Curran, Meer Jacob Rahimi,Salam Alburaiky,Ian Hayes,Henry Oppermann,Cristin Print,Sandra T. Cooper,Polona Le Quesne Stabej
Nicole J Van Bergen, Karen Gunanayagam,Adam M Bournazos,Adhish S Walvekar,Marc O Warmoes,Liana N Semcesen,Sebastian Lunke, Shobhana Bommireddipalli,Tim Sikora,Myrto Patraskaki,Dean L Jones, Denisse Garza,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn